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Quantitative studies  on antibody production require the simultaneous  control of 
many variables,  e.g. cell number, available  space, antigen concentration, in order to 
yield interpretable results from in vivo immune reactions.  For these reasons several 
laboratories have utilized cell transfer in allo- and syngeneic combinations  to investi- 
gate humoral antibody production, delayed hypersensitivity, and homograft reactiv- 
ity: the subject has  been extensively reviewed  by Cochrane and  Dixon  (1).  One 
serious limitation of the transfer system has been the immunological competence of 
the host animal,  which would lead to cytotoxic action against the transferred cells 
in  the case  of allogeneic combinations  (2),  and  to  confusing  additional reactivity 
against the test antigen in syngeneic combinations.  To circumvent either difficulty 
lethal irradiation of the host, or utilization of newborn recipients have been adopted. 
It is evident that these measures  would  not allow a prolonged  observation of the 
activity of transferred cells, as the recipients  would  either die  due to radiation or 
(re)gain  with  time their undesired  competence. 
The main object of the present study was to establish a model system in which 
immunological memory could be measured in a known number of cells and for 
periods up to 6 months. The above mentioned limitation was avoided by se- 
lecting an antigen, human serum albumin, which has been found (3) to be almost 
devoid of immunogenic potency when injected over a large dose range in aque- 
ous solution into mice. In contrast, when it is injected with Freund's adjuvant, 
the same protein is able to elicit a primary response and to "prime" immuno- 
cytes, to produce a  secondary response at their next contact with the antigen 
in any form. Thus, if primed cells are transferred to a nonprimed mouse of the 
same genotype, they are operationally distinct from the cells of the new environ- 
ment in a qualitative rather than quantitative manner: they are the only cells 
capable of responding in a detectable way to the fluid antigen stimulation. The 
possibility of studying in ideal conditions, the history of this "pure" secondary 
response is indeed adequate for the present purpose. This first paper of the 
series describes a convenient way to determine the titers of antisera by the Farr 
technique, and reports the phenomenon by which  the functional implantation 
of competent cells in normal syngeneic mice is severely impaired. This "barrier" 
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is radiosensifive and rises gradually during the first 2  months  of life of the re- 
cipient. 
Materials and Methods 
Mice.--A.SW and (A X  DBA) Fa animals of the same sex, bred in this Institute, were used 
in syngeneic donor-reciplent combination. Since a  detectable reaction against the Y-linked 
antigen was observed in the present as well as in other similar experiments (4), male cells 
were never transferred into female recipients. The donors were injected subcutaneously with 
5 nag human serum albumin (HSA) in Freund's adjuvant at the age of 3 to 4 months. They 
were utilized 40 days to 6  months thereafter. The recipients were used either as  "adults" 
(2 to 4 months old) or at the age specifically indicated in the description of individual experi- 
ments. 
Irradiation Condigions.--A Siemens X-ray machine was the radiation source. The condi- 
tions were: 190 kvP, 15 ma; inherent filtration, 1.5 mm AI; added filtration 1.0 mm AI plus 
0.5 mm Cu. The mice were introduced into separate loculi of a circular perforated Lucite con- 
tainer placed at 50 cm distance from the source. The dose rate at the target was about 100 R 
per min. The dose delivered was measured continuously by a  Philips integrating dosimeter 
whose ionization chamber was fitted in one loculus of the animal container. When not other- 
wise indicated, the "standard radiation dose" delivered was 500 R. 
Spleen Cell Transfer.--Donor mice were sacrificed by decapitation and the blood collected 
for antibody determination. The spleen was gently teased with two pairs of very fine forceps, 
keeping the organ submerged in Eagle's minimal essential medium without serum. The  cell 
suspension obtained was passed several times in a 5 ml syringe fitted with an 18-gauge needle, 
then filtrated through a  200 mesh]in, stainless steel cloth. One spleen yielded an average of 
1.6 X  10  s nucleated cells,  more than 900/0 of which remained "viable" as judged by the dye 
exclusion test. The donor cell suspension was kept at 4°C and injected within 30 rain into the 
tail vein of the recipients, or intraperitoneally (i.p.)  into newborn recipients. 
Anagen.--Chrystalline HSA, batch 7749  from the Nutritional Biochemical Corporation, 
Cleveland was used  throughout the experiments to immunize donors and  to  challenge re- 
cipients. This HSA preparation was shown to give a single precipitation line in immunoelec- 
trophoresis when confronted with either anti-HSA or with anti-nornml human serum anti- 
bodies.  For  donor immunization, equal parts of  a  20 mg/ml solution and Difco complete 
adinvant (Difco Laboratories, Detroit) were thoroughly mixed and injected subcutaneously 
in aliquots of 0.5 ml/mouse to two sites of the abdomen. Challenge of recipients consisted in 
an i.p. injection of 0.2 ml of a solution of HSA in saline. The standard challenge dose was 0.1 
mg/mouse, given shortly (within 1 hr) after cell transfer. This dose failed to elicit any primary 
response from adult intact nonirradiated mice. For the titration of antibodies, lmI-labeled 
human serum albumin B.P. was obtained from the Radiochemical Centre, Amersham, Eng- 
land. 
Sera.--Recipients were bled on day 10, 20, and 30 after having received the cell transfer 
and challenge, by puncturing the retroorbital sinus with a  Pasteur pipette.  2  or 3 hr after 
clotting at  room  temperature  individual sera  were  separated  by  centrifugation and  kept 
frozen  at  --20°C  until  the  moment  of  titration. 
Serology.--The antigen-binding capacity  (ABC) of the sera was determined by the  tech- 
nique described by Farr (5) to which several modifications were applied. Essentially, a  fixed 
amount of 1181 HSA (0.25 ~g in 0.25 ml) was mixed with an equal amount of test serum, di- 
luted in borate buffer at pH 8.2, containing 10% normal mouse serum (NMS). Standard di- 
lutioas employed were 1: 5, 1:10, 1: 25, 1:50, 1:100, 1:250, and 1: 800. Contact between anti- 
gen-antibody was allowed for 30 rain after which 0.5 ml saturated ammonium sulfate (SAS) ~ANCO  CELADA  3 
was added to each tube; after 60 rain the precipitate was separated by centrifuging at 4900 g 
for 20 rain and washed once in 1 ml 50% SAS in borate. All operations were carried out at 
room temperature. The final precipitate was dissolved in 1 ml borate buffer and counted in a 
Tracerlab well type scintillator. Each experiment had the following standards: (a) two posi- 
tive controls consisting of tubes which received the normal amount of albumin and buffer 
but were not processed with SAS; and (b) two negative controls for the nonspecific albumin 
binding or trapping, consisting of albumin plus NMS-buffer which was regularly processed 
with SAS. The maximum nonspecific binding allowed was 4%. Usually 1.5 to 3% precipitation 
was found in the negative control tubes. The determination of the ABC, in terms of gg- 
bound antigen per mi undiluted serum, was calculated from the fraction of albumin precipi- 
tated by the SAS when preincubated with a  given serum dilution. This fraction, called ib, 
corresponds to the amount of albumin which is bound when 1 ml of a given serum dilution is 
incubated with 1 ml of buffer containing 1/~g of albumin. The details of these calculations, 
which were standardized through a set of preliminary experiments, are described in the first 
section of the Results. 
RESLrLTS 
Antigen M~ing as a fumtion of antibody c~centration.--The aim of the ex- 
periments described in this section was to establish a reliable way of determining 
the titer of a given serum by the Farr technique. The fraction of 18, I-labeled 
HSA bound by an aliquot of antiserum depends on the concentration of anti- 
body molecules as well as on their types.  The latter parameter, first observed by 
Farr himself (5) can be disregarded in the present study, since both donor and 
recipient's sera were shown by chromatographic  separation on Sephadex, to 
contain exclusively 7S antibodies, as expected for a late primary and a secondary 
response. The plot of the fraction of albumin bound (fb) by antisera of differ- 
ent strengths against serum dilution yielded roughly parallel S-shaped curves. 
Sigmoidal curves are inconvenient if one wishes to calculate the ABC of an 
antiserum using a small number of dilutions but without losing accuracy. Thus 
the next step was to transform them into straight lines. This was accomplished 
to a satisfactory degree by using Von Krogh's empirical equation, i.e. by sub- 
stituting fb with the expression fb/(1  --  fb). Log [fb/(1  --  fb)] was plotted 
against the concentration (expressed as log gl/ml) for several antisera (Fig.  1). 
The resulting functions were linear and parallel over about two log units, cor- 
responding to fb values from about 10 to 75 %. Within these limits they could 
be described with the general formula 
Y =  a +  0.75 x  (1) 
where Y  =  log gl/ml, X, =  log fb/(1 -  fb), 0.75 is the slope, and a is the inter- 
cept  characteristic for  each serum. This  intercept  expresses  the  logarithmic 
concentration of the serum when log [fb/(1 -- fb)] =  0; fb/(1 -- fb) is then = 
1, and fb =  0.5: it corresponds to the log ttl undiluted  antiserum necessary to 
bind 0.5/~g HSA. The intercept a  is readily calculated by applying formula (1) 
to any fb value observed with a  given serum, provided that it is between 10 4  ADOPtiVE  IMMUNOLOGICAL MEMORY IN MICE.  I 
and  75%,  and  is expressed  in  log/zl in  1 ml of serum dilution: 
a  =  log#l/ml -- 0.75 log [fb/(1  -- fb)]  (2) 
To obtain the ABC (/zg HSA bound by 1 ml of undiluted antiserum),  the num- 
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FIG.  1.  Linear relationship  between log antiserum  concentration  and  log fb/(1  --  fb), 
obtained by titrating 4 different antisera. Fb is the fraction of HSA bound by antibody in the 
reaction tube. The slope of the curves is 0.75. The intercept at log fb/(1 -- fb)  =  0 represents 
the antiserum concentration necessary to bind  50%  of the HSA present. 
ber  of ~I in  1 ml of undiluted  serum  (= 1000)  should be divided by  twice  the 
number  of pl necessary  to bind 0.5 #g HSA, or 50 %  of  the  albumin present. 
In log terms this is written: 
log ABC -- 3.000  --  (a +  0.30103),  (3) 
or by approximation 
log ABC =  2.700  -- a FRANC0 CELADA 
The  accuracy of determining  the  ABC of an antiserum  by this  method  was 
tested by performing 6 parallel independent titrations on the same sample. This 
was repeated with two pools of antisera in serial dilutions. The mean log ABC 
and its 95 %  confidence limits, calculated from the.fb of a  series of serum con- 
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Fxo. 2. Calculation  of the titer  (log A.BC) of two antisera  by the formula described in 
the text. Each point is the mean log ABC obtained from 6 independent dilutions of the same 
serum, -4- the 950/0 confidence limits. Only the values calculated from per cent binding 10 to 
75 are considered reliable. The dotted lines show the best  estimates  of the titers.  In paren- 
thesis is the mean per cent albumin bound at each dilution of antiserum. 
centxations axe shown in Fig.  2. The results  confirm that the useful range  to 
calculate ABC is limited to serum concentrations binding between l0 and 75 %. 
Within these limits the mean titers obtained are statistically not different from 
each other and axe subject to comparable variation. Outside these limits, vari- 
ation tends to increase at both ends, while the calculated titer for fractions of 
HSA bound in the order of 85 to 95 % is markedly higher as well. 
Table I  shows the individual  data  from the  titration  of the pool with  the 
higher ABC. The distribution of the individual log ABC values is quite narrow 6  ADOPTIVE  rMMUNOLOGICAL  MEMORY IN  MICE.  I 
TABLE  I 
Test  of  the  Accuracy of  ABC  Determination 
Serum concentration 
td/ml 
10 
2.5 
1.25 
0.62 
0.00 
HSA binding (fb X  100) 
Individual tubes 
90.1 
97.0 
93.4 
96.3 
93.2 
99.0 
51.5 
49.2 
61.0 
54.2 
51.4 
51.9 
28.6 
24.8 
16.3 
22.2 
26.3 
35.6 
14.4 
14.3 
13.0 
10.6 
9.6 
14.8 
6.7 
6.3 
7.2 
8.1 
6.6 
6.0 
2.0 
Log ABC calculated 
Mean  Individual tubes  Mean and  sv 
87.8  Out of useful range 
53.1 
25.6 
12.8 
2.010 
1.990 
2.140  2.040 
2.057  s  =  0.07 
2.019  s~ =  0.03 
2.017 
2.003 
1.939 
1. 777  1.950 
1.892  s  =  0.07 
1.965  sl =  0.03 
2.112 
2.021 
2.019 
1.982  1.974 
1.910  s  =  0.07 
1.872  sl =  0.029  2.041 
6.8  Out of useful range 
ABC geometric 
mean 4-95% 
confidence 
limits 
109  4-  14 
89  4-  15 
94  -4-  14 
within  the  useful  range  (in  this  instance  8  to  61%  binding),  the  percentual 
standard  deviation of the distributions being less than 4. 
The Adoptive  Response.--Several  characteristics  of  the  adoptive  secondary 
response against albumin  have been described  by Dresser  (6)  and  by M~ikel~. I~RANCO CELADA  7 
and Mitchison  (7, 8). In agreement with the data of these investigators,  the 
results from preliminary  experiments  in  the present  study are  the following. 
After transferring  10  ~ presensitized spleen  cells to irradiated  syngeneic recip- 
ients and challenging  them with a small dose (0.1 mg) of fluid HSA, the anti- 
body response of these spleen cells (a) rose at a  high rate during  the first  10 
days, reached a peak between 10 and 20 days, and decayed slowly thereafter; 
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FIo. 3. Radiosensitivity of the barrier to syngeneic transplantation.  The relative antibody 
response of 10  T  transferred spleen cells is plotted (ordinate) against decreasing doses of X-rays 
admin|~tered to the recipient. 
(b) was about 200 times more efficient than the response of unchallenged cells, 
and (c)was 50 to 100 times more efficient than the response of cells transferred 
into nonirradiated  adult recipients of the same strain.  The fact, evident from 
observation (c), that donor cells were functionally impaired as if they had en- 
countered a  barrier when  transferred  into  intact  adult  recipients  was quanti- 
tatively studied in a series of experiments. These were designed to answer the 
following questions concerning the importance of the recipient environment in 
the transplantations  of competent cells: (a) how radiosensitive is the "barrier"; 
(b)  could  it  be  based  on  recipient's  immune  reactivity  against  donor  cells ADOPTIVE  ~t4"M~NOLOGICAL  MEMORY  IN MICE.  I 
prompted by an unexpected residual heterozygosis in the inbred strain used; 
and (c) is it dependent on the age of the recipients? 
Impact of irradiation of the recipients.--To measure the effect of X-irradiation 
of the host on the function of antibody forming transferred cells the following 
experiment was performed. Groups of prospective recipients were exposed to 
600, 500, 300,  100, and 0  R. Within  1 hr they were transferred 107 syngeneic 
spleen cells from a  single donor pool. The challenging tISA injection was ad- 
ministered immediately thereafter. The results are shown in Fig. 3. The relative 
TABLE II 
Test/or Possible tIomografl Reaction Against Transfer Cdls 
Pretreatment of recipients 
None 
Intraperitoneal  injection of 2 X 10: 
irradiated syngeneic  cells 
,og  ABC 
~dividual 
0.714 
0.919 
1.112 
0.825 
1.462 
1.379 
0.844 
0.951 
0.923 
1.171 
0. 749 
0.837 
1.186 
0. 750 
Mean 
1.022 
~. 939 
"Student" t test 
0.630  (t  value for 13  degrees of 
freedom =  2.160) 
antibody response in each group of mice is plotted on a semilog scale against 
the X-ray dose administered to the recipients. The antibody level found in 600 R 
recipients was taken as reference point= 1, as higher doses do not further im- 
prove the conditions for the transferred cells to function. The effect of 500 R 
was not significantly different from the reference dose, while an increasing im- 
pairment of antibody production was observed with 300 and 100 R. These doses 
allowed about 20 and 5 % of the response, respectively, while  1.5%  was found 
in nonirradiated mice. 
Test for Possible Homograft Reacti~ty.--The strains of mice used in these ex- 
periments are highly inbred and they are checked at intervals for intrastrain 
acceptance of skin grafts. However, in view of (a) the possible different sensi- 
tivity of skin and spleen cell graft rejection tests (2),  (b) the possibility that I~RANCO CELADA  9 
lymphoidal cells might carry antigens which are not expressed on cells of a dif- 
ferent lineage (9), (c), the recently reported high incidence of spontaneous mu- 
tat.ions at histocompatibility loci (10), and (d) the parallelism at an interval of 
5330 R, of the radiosensitivity profile of the allogeneic transplantation barrier 
Z0. 
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10tells. 
~lmg HSA 
Days after transfer 
Fzo. 4.  Antibody response of 107 donor spleen cells transferred: A, into 500 R  irradiated; 
B, 30 days old; C, 39 days old; D, 66 days old; and E, 120 days old, nonirradiated recipients. 
Groups of 6 to 10 mice. Plotted are mean log ABC 4- 95% confidence limits. 
as measured in a system closely resembling the present one (11) and of the syn- 
geneic barrier iUustrated in Fig. 3, the existence of any degree of immune reac- 
tivity of the recipients against the donor cells  had to be carefully excluded. 
This was done by transferring immune spleen cells in the usual way to intact 
recipients which had been pretreated, 1 wk previously, with 2 X  107 cells  of a 
pool from several syngeneic animals. These cells were irradiated with 3000 R 
in vitro, and inoculated i.p. The results, in Table II, show the tilers obtained 
in the experimental groups, as compared with the controls which were not pre- 1.5_ 
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sensitized.  There is a  clear demonstration that homograft reaction against the 
hypothetical  antigenic  specificities  of the  donors plays no  role in this  model 
system, or else preimmunized recipients would have reacted more strongly, with 
a  resulting lower anti-HSA titer in this group. 
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FIG. 5. Increase with recipient's age of the barrier to functional transplantation  of donor 
cells. The relative inhibition  of donor cells (log ABC in irradiated  controls  -- log ABC in 
experimental groups) is plotted  against the age of recipients. Each point is the mean of 5 to 
10 observations, 4-95% confidence limits. The fitted regression line from 2 to 65 days of age 
is expressed by the formula Y =  0.493 q- 0.024 X. For Y -- 0, X  =  --20.9 days. 
Age Deperutence of the Barrier.--It was observed that irradiated recipients of 
varying ages from 20 days to over 4 months provided an equally good environ- 
ment for the production of antibodies  by donor cells.  By contrast,  when  the 
same pool of donor cells was transferred  to groups of intact mice of different 
ages the ABC of their  serum  dropped  gradually from 50%  of the  irradiated 
recipients (control), in newborns, to less than 2 % in adults (60 to 80 days old). FIIANCO CELADA  II 
The results of one experiment are shown in Fig. 4, while the complete series of 
experiments involving about 150 experimental recipients and 100 controls (ir- 
radiated recipients), is illustrated in Fig. 5. In this graph (Fig. 5) the barrier to 
functional "take" of donor cells is represented as the difference log ABCoontrol = 
ABCexperlment,1 and is plotted against recipient's age. Each experiment usually 
included one or two experimental and one control group, with 5 to 10 animals 
per group. The individual log ABC values obtained at each bleeding (10,  20, 
and 30 days) were subtracted from the control mean log ABC  of the  corre- 
sponding bleeding. Each point on the graph in Fig. 5 is the mean of the pooled 
values from the three bleedings. The 95 % confidence limits were calculated as 
follows: tx(SD)/~t where t is Student's value corresponding to p=0.0S for n--1 
degrees of freedom, n is the number of animals in the experimental group, and 
SD is the mean of the standard deviations computed for each bleeding. 
A possible error, due to the change of blood volume with age, was avoided 
by always using "irradiated control" mice of the same age as the experimental 
animals. 
Despite  considerable  variation  within experiments the  resulting  function 
shows a linear rise over the first 2~ months of age, and reaches a plateau there- 
after. The regression line, fitted to the data from 2 to 65 days of age is expressed 
by the formula: Y =  0.493  ~  0.024 X. By extrapolation, the barrier (Y) is 0 
at age --20.9 days; this time corresponds to the very beginning of the embryonic 
life of the mouse. 
DISCUSSION 
The method for calculating ABC described in the first section of this paper 
is useful as it readily allows extrapolation from a wide range of binding of HSA 
to the corresponding 50 % binding. Thus, the titer of an antiserum can be ob- 
tained with satisfactory accuracy from a  single tube, provided the binding is 
between 10 and 75 %. The results are comparable or better than other methods 
of calculation proposed (5), and the variation within repetitions is small. 
The existence of an impairment of the functional activity of antibody-forming 
cells transferred into intact syngeneic recipients, and the abrogation of this 
state by previous exposure of the recipient to radiation, has been observed by 
Dresser (6)  who measured the adoptive response of mice against BSA by the 
accelerated elimination of mIodinated antigen from their blood stream, and by 
Weiler, who followed the antiphage titer in mice injected with syngeneic im- 
mune ascites cells (12). This phenomenon could be quantitated in the present 
transfer system, although it is not known whether the same number of cells are 
implanted in intact and irradiated recipients but are allowed a different rate of 
antibody production, or a  different number of cells  "take" in the first place. 
The total body radiation doses (500 to 600 R), which abrogate the barrier are 
in the same order of magnitude of those necessary to inhibit for a limited period 12  ADOPTIVE IMMUNOLOGICAL  M_E~rORy IN M_ICE. I 
a primary immune response of intact mice to heterologous antigen; such a re- 
sponse in turn has been shown to be as radiosensitive at a cellular level as any 
rapidly dividing cell population, both in vivo (13,  14,  11) and in vitro. Thus 
these  data  are  compatible with  the  existence of a  competition between  the 
inoculum and the recipients' own lymphoidal cells. It is known that there is an 
upper limit in the number of lymphoidal, and hence competent cells in the intact 
animal. Radiation,  by destroying most of the recipients dividing cells,  would 
make "space" for the functional implantation of the donor cells. It should how- 
ever be pointed out that the meaning of such concepts like "competition" and 
"space" as used here is still vague, since information is wanting with regard to 
the possible importance, as regulatory factors, of (a), humoral versus cell con- 
tact limitation of lymphoidal growth, (b) specific or nonspecific gamma globulin 
feedback on antibody production, and (c), central versus microenvironmental 
stimulation/depression of mitosis, which is regarded as necessary for the build- 
ing up of a complete immune response. 
To extrapolate from the data here obtained in  the  transfer model  to  the 
regulatory mechanisms of the intact mouse, one should assume that transferred 
and autochthonous cells being derived from the same original genotype share 
the same fate. This seems to be a reasonable assumption: hence a working hy- 
pothesis of cellular homeostasis  should certainly cope with the developmental 
aspect shown by the present experiments, i.e. the growth of repressive forces 
during a period beginning in early embryonic life and ending at the full matu- 
ration of the animal. 
The results with newborn or very young mice confirm the difference between 
the rabbit and several other laboratory animals as far as the ability of the new- 
born to support an immune response  by transferred adult  competent  cells is 
concerned (1). A  number of parameters of the ontogenic development of the 
mouse and particularly of its lymphoidal tissue show a gross parallelism or time 
coincidence with the rise of the barrier to syngeneic implantation of immuno- 
logically competent cells. For instance Metcalf's data on thymus (16) and lymph 
node (17) growth, Makinodan's measure of the relative eificiency of the primary 
response by spleen cells (18), and Wigzell's estimate of the increase of hemolytic 
plaque-forming cells in the spleen (19), all present a maximum growth rate be- 
tween birth and the age of 2 months, a  period which also includes the main 
weight gain of the animal. However, a more quantitative comparison of these 
parameters reveals that in the young mice the doubling time of body,  spleen 
and thymus weight is about 2 wk, while the potential antibody-forming cells 
double in 1 wk or less. The doubling time of the "barrier" calculated from the 
present data is  about  12 days. This suggests that the barrier is not directly 
correlated with the actual number of mature immune cells present in the animal, 
but is rather an expression of a more general regulation of the lymphoidal sys- 
tem. The interpretation of this phenomenon as central is favored in view of the ~:UA~NCO CELADA  13 
results of current experiments in this laboratory, which indicate that 1-yr-old 
irradiated recipients are a  significantly worst environment for the donor cells 
than their 3-month-old similarly treated counterparts. Since it is known that 
in the senescent mouse the content of ab-forming cells in the spleen declines, 
while the body and spleen weight do not (18, 19),  one should have expected an 
equal or better take in old mice if the barrier was due to simple competition 
among immunologically competent cells. 
SUMMARY 
Antibody-forming cells  suspended from a  mouse spleen and transferred to 
intact animals of the same genotype face a barrier which severely affects their 
capacity to implant and/or to function. 
This phenomenon was quantitatively studied in a model system which, uti- 
lizing the immunogenic properties of human serum albumin in mice, allows the 
secondary response of the transferred cells to be followed without interference 
from the host's own reactivity. The barrier to syngeneic transplantation was 
found (a) to be radiosensifive (S00 R X-rays to the recipient abolishes it and 
insures optimal functional conditions to the donor cells)  in the same order of 
magnitude of other mammalian systems involving rapidly dividing cell popula- 
tions, and (b)  to depend upon the age of the recipient: its linear rise is docu- 
mented from birth time (when ,-~ 50 % of the maximal immune capacity of the 
transfer is expressed) to the age of 2 months (~  1%). The significance of these 
findings to the immune response and to cell growth and differentiation is dis- 
cussed. 
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